Skip to main content
. 2018 Oct 7;17:1533033818802813. doi: 10.1177/1533033818802813

Figure 5.

Figure 5.

(A) In a group of patients with WBC 4.0 to 7.0, the prognosis of patients with ≤2 and ≤2 cycles of chemotherapy was no different (HR: 0.560, 95% CI: 0.248-1.261, P = .161). B, In a group of patients with WBC ≥7.0, patients with ≥2 chemotherapy cycles have a better prognosis than patients with ≤2 chemotherapy cycles have a better prognosis (HR: 0.573, 95% CI: 0.338-0.971, P = .037).